<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Pathkey.ai Limited — News on 6ix</title>
<link>https://6ix.com/company/pathkeyai-limited</link>
<description>Latest news and press releases for Pathkey.ai Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 11 May 2026 03:41:05 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/pathkeyai-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d5aeccbeedb30cb6f9af62.webp</url>
<title>Pathkey.ai Limited</title>
<link>https://6ix.com/company/pathkeyai-limited</link>
</image>
<item>
<title>PKY Appoints AI Systems and Defence Technology Leader as CEO</title>
<link>https://6ix.com/company/pathkeyai-limited/news/pky-appoints-ai-systems-and-defence-technology-leader-as-ceo</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/pky-appoints-ai-systems-and-defence-technology-leader-as-ceo</guid>
<pubDate>Mon, 11 May 2026 03:41:05 GMT</pubDate>
<description>PKY Appoints AI Systems and Defence Technology Leader as CEO</description>
</item>
<item>
<title>Response to ASX Price Query</title>
<link>https://6ix.com/company/pathkeyai-limited/news/response-to-asx-price-query-783</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/response-to-asx-price-query-783</guid>
<pubDate>Wed, 29 Apr 2026 04:05:11 GMT</pubDate>
<description>Response to ASX Price Query</description>
</item>
<item>
<title>PKY to Acquire AI Semiconductor Design Verification Platform</title>
<link>https://6ix.com/company/pathkeyai-limited/news/pky-to-acquire-ai-semiconductor-design-verification-platform</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/pky-to-acquire-ai-semiconductor-design-verification-platform</guid>
<pubDate>Wed, 29 Apr 2026 00:05:11 GMT</pubDate>
<description>PKY to Acquire AI Semiconductor Design Verification Platform</description>
</item>
<item>
<title>PKY Secures Key Commercial Contract with Imunexus</title>
<link>https://6ix.com/company/pathkeyai-limited/news/pky-secures-key-commercial-contract-with-imunexus</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/pky-secures-key-commercial-contract-with-imunexus</guid>
<pubDate>Thu, 02 Apr 2026 02:55:07 GMT</pubDate>
<description>PKY Secures Key Commercial Contract with Imunexus</description>
</item>
<item>
<title>PKY - Appendix 4D & Half Year Results</title>
<link>https://6ix.com/company/pathkeyai-limited/news/pky-appendix-4d-and-half-year-results</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/pky-appendix-4d-and-half-year-results</guid>
<pubDate>Thu, 26 Feb 2026 14:01:03 GMT</pubDate>
<description>PKY - Appendix 4D & Half Year Results</description>
</item>
<item>
<title>Response to ASX Price and Volume Query</title>
<link>https://6ix.com/company/pathkeyai-limited/news/response-to-asx-price-and-volume-query-206</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/response-to-asx-price-and-volume-query-206</guid>
<pubDate>Wed, 18 Feb 2026 07:27:02 GMT</pubDate>
<description>Response to ASX Price and Volume Query</description>
</item>
<item>
<title>Quarterly Activities & Cashflow Report</title>
<link>https://6ix.com/company/pathkeyai-limited/news/quarterly-activities-and-cashflow-report-126</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/quarterly-activities-and-cashflow-report-126</guid>
<pubDate>Fri, 30 Jan 2026 09:11:04 GMT</pubDate>
<description>Quarterly Activities & Cashflow Report</description>
</item>
<item>
<title>Offer Document</title>
<link>https://6ix.com/company/pathkeyai-limited/news/offer-document-12</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/offer-document-12</guid>
<pubDate>Thu, 04 Dec 2025 13:09:10 GMT</pubDate>
<description>Offer Document</description>
</item>
<item>
<title>PKY Completes $2.5m Placement and Launches Rights Issue</title>
<link>https://6ix.com/company/pathkeyai-limited/news/pky-completes-dollar25m-placement-and-launches-rights-issue</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/pky-completes-dollar25m-placement-and-launches-rights-issue</guid>
<pubDate>Thu, 27 Nov 2025 03:49:16 GMT</pubDate>
<description>PKY Completes $2.5m Placement and Launches Rights Issue</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/pathkeyai-limited/news/trading-halt-1506</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/trading-halt-1506</guid>
<pubDate>Tue, 25 Nov 2025 03:43:15 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>Pathkey.AI and Armstrong Clinical Partner on AI Trials</title>
<link>https://6ix.com/company/pathkeyai-limited/news/pathkeyai-and-armstrong-clinical-partner-on-ai-trials</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/pathkeyai-and-armstrong-clinical-partner-on-ai-trials</guid>
<pubDate>Wed, 12 Nov 2025 03:10:11 GMT</pubDate>
<description>Pathkey.AI and Armstrong Clinical Partner on AI Trials</description>
</item>
<item>
<title>TrialKeys AI Predictions Continue to Outperform</title>
<link>https://6ix.com/company/pathkeyai-limited/news/trialkeys-ai-predictions-continue-to-outperform</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/trialkeys-ai-predictions-continue-to-outperform</guid>
<pubDate>Thu, 09 Oct 2025 02:38:16 GMT</pubDate>
<description>TrialKeys AI Predictions Continue to Outperform</description>
</item>
<item>
<title>Pathkey Advances TrialKey with Drug-Level AI Features</title>
<link>https://6ix.com/company/pathkeyai-limited/news/pathkey-advances-trialkey-with-drug-level-ai-features</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/pathkey-advances-trialkey-with-drug-level-ai-features</guid>
<pubDate>Thu, 18 Sep 2025 03:41:08 GMT</pubDate>
<description>Pathkey Advances TrialKey with Drug-Level AI Features</description>
</item>
<item>
<title>Successful TrialKey Observational Predictions</title>
<link>https://6ix.com/company/pathkeyai-limited/news/successful-trialkey-observational-predictions</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/successful-trialkey-observational-predictions</guid>
<pubDate>Mon, 08 Sep 2025 02:54:20 GMT</pubDate>
<description>Successful TrialKey Observational Predictions</description>
</item>
<item>
<title>Preliminary Financial Report - 30 June 2025</title>
<link>https://6ix.com/company/pathkeyai-limited/news/preliminary-financial-report-30-june-2025</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/preliminary-financial-report-30-june-2025</guid>
<pubDate>Fri, 29 Aug 2025 02:57:40 GMT</pubDate>
<description>Preliminary Financial Report - 30 June 2025</description>
</item>
<item>
<title>Opyl Signs Service Agreement with Innovatrix</title>
<link>https://6ix.com/company/pathkeyai-limited/news/opyl-signs-service-agreement-with-innovatrix</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/opyl-signs-service-agreement-with-innovatrix</guid>
<pubDate>Tue, 12 Aug 2025 03:46:19 GMT</pubDate>
<description>Opyl Signs Service Agreement with Innovatrix</description>
</item>
<item>
<title>Treasury Update</title>
<link>https://6ix.com/company/pathkeyai-limited/news/treasury-update</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/treasury-update</guid>
<pubDate>Thu, 26 Jun 2025 03:14:16 GMT</pubDate>
<description>Treasury Update</description>
</item>
<item>
<title>OPL & Innovatrix to Launch Clinical Trial Insurance Product</title>
<link>https://6ix.com/company/pathkeyai-limited/news/opl-and-innovatrix-to-launch-clinical-trial-insurance-product</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/opl-and-innovatrix-to-launch-clinical-trial-insurance-product</guid>
<pubDate>Wed, 18 Jun 2025 04:35:07 GMT</pubDate>
<description>OPL & Innovatrix to Launch Clinical Trial Insurance Product</description>
</item>
<item>
<title>OPL Deepens Global AI Collaborations - Cardialysis & Evestia</title>
<link>https://6ix.com/company/pathkeyai-limited/news/opl-deepens-global-ai-collaborations-cardialysis-and-evestia</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/opl-deepens-global-ai-collaborations-cardialysis-and-evestia</guid>
<pubDate>Thu, 12 Jun 2025 03:18:18 GMT</pubDate>
<description>OPL Deepens Global AI Collaborations - Cardialysis & Evestia</description>
</item>
<item>
<title>OPL Completes Strategic Review</title>
<link>https://6ix.com/company/pathkeyai-limited/news/opl-completes-strategic-review</link>
<guid isPermaLink="true">https://6ix.com/company/pathkeyai-limited/news/opl-completes-strategic-review</guid>
<pubDate>Tue, 10 Jun 2025 03:15:14 GMT</pubDate>
<description>OPL Completes Strategic Review</description>
</item>
</channel>
</rss>